MGI launches first European production site in Latvia

Latvia MGI Tech (MGI Latvia) a subsidiary of MGI Tech Co. (MGI), has launched a large-scale production line in Latvia. As MGI’s largest regional hub for the European market, the facility based in Riga will see the assembly and production of DNBSEQ-G400 gene sequencing instruments and HotMPS reagents. This is MGI’s first European production site.

“Europe has always been a technology leader and one of our key markets. The launch marks another key milestone for MGI’s development of its business in Europe as we continue our quest to provide effective real-time, comprehensive, and life-long solutions for our customers and partners in the region,” stated Jian Liu, Executive Vice President of MGI at the launch. 

At the opening ceremony, guests unveiled the first G400 instrument produced at the Latvia site. MGI plans to increase overall capacity gradually in the future with a local team of engineers to support production and quality control. In addition, MGI Latvia will provide aftersales support and maintenance services.

Since beginning operations in 2019, MGI Latvia has been a hub for research and development, production, logistics and specialised training in Europe and other international regions. The 7000-square-metre facility is home to a Global Product Application Demo Centre and a Customer Experience Centre, which opened last year to showcase MGI’s latest technology. Besides production activities, MGI Latvia has collaborated with local and regional partners in several funded research programmes, including Horizon 2020. 

“I’m delighted to see how our Riga facilities evolve from serving as an office, warehouse and Customer Experience Center to MGI’s first European production site,” said Dr. Yong Hou, General Manager of MGI Europe and Africa. “We understand how important regional production and supply is for our customers and look forward to increasing our capacity in Europe moving forward to accommodate demand,” he added. 

The DNBSEQ-G400 is a day-to-day, medium throughput benchtop sequencer that can support a variety of different sequencing modes, thanks to its new Flow Cell system that provides the option to run one or two flow cells with two types of flow cells and various read length options from SE50 to SE400 or PE300. In addition, it adopts optimised optical and biochemical systems, which effectively speed up the process and provide users with a more streamlined sequencing experience.

The HotMPS sequencing chemistry has been developed to be used on DNBSEQ-G400 and is compatible with commonly used library preparation methods. Built upon the combinatorial Probe Anchor Synthesis (cPAS) technology found in MGI’s core DNBSEQ™ technology, HotMPS demonstrates low error rate, low duplication rate, and low index hopping, while achieving fundamental breakthroughs in the nucleotides and enzymes used in the sequencing process. 

Source: Press release (www.en.mgi-tech.com)
Publicity photo